Combined insulin/GLP-1 pens near market.
Eva
E
von Schaper
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D017277:Drug Approval; D004338:Drug Combinations; D052216:Glucagon-Like Peptide 1; D006801:Humans; D007004:Hypoglycemic Agents; D007328:Insulin; D014481:United States; D014486:United States Food and Drug Administration
D004338:Drug Combinations; D007004:Hypoglycemic Agents; D007328:Insulin; D052216:Glucagon-Like Peptide 1